Conmed Receivables

Conmed (CNMD) currently reports a receivables of $240M as of June 2026. That compares with $230M in the prior-year period — up 2.4% year over year. Use the charts on this page to explore Conmed's receivables history and peer comparisons.

Conmed's receivables increased from $230M to $240M — a 2.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Conmed reported $240M in receivables as of June 2026. That compares with $230M in the prior-year period — up 2.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $240M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Conmed, and consider following CNMD for alerts when major investors trade the stock.

Conmed is classified in the Healthcare sector. On receivables, it currently shows $240M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CNMD with unrelated industries.